Dávid Dankó, Ph.D

Dr Márk Péter Molnár, Ph.D

Goals and Purpose of Health Technology Assessments ( HTA)

EN_AC_HE_A

Main

Advocacy Center

Schizophrenia

Psoriasis

Chronic lymphocytic leukemia (CLL)

Multiple Myeloma

Prostate Cancer

Crohn's disease

Major Depressive Disorder

Pulmonary Hypertension

Multiple Sclerosis

Psoriatic arthritis

Privacy Policy

Cookies

Terms Of Use

YouTube

Janssen

zdj_03_DDanko

D&aacute;vid Dank&oacute; is founder and managing partner of Ideas &amp; Solutions (I&amp;S), an independent research and consultancy firm which provides health policy and market access advisory services to health insurance organizations and pharma and medical device companies with a focus on emerging and middle-income markets.
D&aacute;vid has 16 years of experience in health care management &amp; the funding of pharmaceuticals and medical devices. Until 2010 he was member of the executive team for pharmaceutical reform in Hungary as Deputy Director of Reimbursement at the national health insurance fund. Previously he also held a position as research leader at the Corvinus University of Budapest. He speaks regularly at conferences and workshops on pharmaceutical and medical device policies, gives payer communication and negotiation trainings to multinational companies and authorities, and participates at international advisory boards.
D&aacute;vid is peer-reviewer and editorial board member of three health economics and market access journals. He is also co-editor of a university textbook titled &lsquo;Pharmaceutical Reimbursement&rsquo; and co-author of the Pharmacoeconomics and Outcomes Research Guidelines for India. D&aacute;vid works in English, Russian and Italian, and also speaks German, French and Portuguese.

zdj_02_Mark_Molnar

M&aacute;rk P&eacute;ter Moln&aacute;r is a research leader at the Institute of Management of the Corvinus University of Budapest, where he recently finalized his PhD thesis on managing patients&rsquo; adherence to medicinal treatment, especially on the economic effectiveness of therapy management programmes. Within his academic role he lectures pharmaceutical and medical device reimbursement, health care management and health care financing, co-edited a comprehensive textbook on pharmaceutical reimbursement, is a regular speaker at conferences and has had several publications in Hungarian and international journals.
As partner of Ideas &amp; Solutions, an advisory firm offering strategic consultancy services to pharmaceutical and medical device manufacturers, with special focus on middle-income countries, he is also engaged in several consulting projects. As consultant his current focuses are:
<ul>
<li>Balanced drug assessment (HTA) systems for middle-income countries</li>
<li>Communication strategies between payers, key opinion leaders and pharmaceutical industry</li>
<li>Transparency of pharmaceutical decision-making processes</li>
<li>New business &amp; organizational models for innovative pharmaceutical companies build on patient focused services</li>
</ul>
He graduated from Semmelweis University of Budapest and University of West Hungary in 2005 with degrees in medical science and economics, respectively.
From 2005 to 2006, he worked as health economist at the Hungarian Office for Health Technology Assessment. Between 2006 and 2010, he headed the Department of Reimbursement at the Hungarian National Health Insurance Fund, where he was responsible for the reimbursement system for drugs, nutritions, and later also medical devices. The team he headed between 2006 and 2010 led the Hungarian drug reimbursement system through a radical change, resulting in more efficient, transparent and stable operations. In 2007, the Minister of Health awarded him with Batthy&aacute;ny-Strattmann L&aacute;szl&oacute; award for these efforts. For his prominent work in the field of social security, he earned Szent Krist&oacute;f Plaquette in 2008.
In 2010 M&aacute;rk founded the Hungarian Association for Communication in Healthcare, he is still the president of the organization.
In 2010 M&aacute;rk founded a company based on his own idea named PraxisPlatform which later became a joint venture with the Hungarian subsidiary of the Deutsche Telekom Group. PraxisPlatform offered patient communication and therapy management services to 200.000 patients. In 2014 the leading Hungarian pharmaceutical wholesaler bought the company. PraxisPlatform was able to improve patient adherence significantly based on scientific studies.
PHPL/OTH/1017/0010

EN_AC_HE_B

Health Technology Assessment (HTA) approaches

EN_AC_HE_C

Pillars of economic evaluation

EN_AC_Chapter-8

Message from Health Economics experts

Do you want to know more on the evaluation of medicines and medical devices? Have a look at this video and learn more about Health Technology Assessments ( HTA)benefits and risks.

Do you want to know more on the evaluation of medicines and medical devices? Have a look at this video and learn more about  Health Technology Assessments ( HTA)benefits and risks.